Insider trading

Period: 120 months Stock: AUPH + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

103 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

103 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

103 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

103 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
103 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
103 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

103 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Sep 2026
Robertson Stephen P. Chief Legal Officer
Sold at will
$190.43K 11,939 at 15.95
2.0%
Not planned
21 Aug 2026
Robertson Stephen P. Chief Legal Officer
Sold at will
$355.95K 20,975 at 16.97
3.4%
Not planned
2 Jun 2026
TANG KEVIN Chief Executive Officer · indirect
Bought
$3.15M 206,005 at 15.28
1.6%
1 Jun 2026
TANG KEVIN Chief Executive Officer · indirect
Bought 2×
$5.25M 343,620 at 15.28
2.8%
29 May 2026
TANG KEVIN Chief Executive Officer · indirect
Bought 2×
$4.06M 264,981 at 15.31
2.2%
3 Mar 2026
TANG KEVIN Director · indirect
Bought
$2.62M 184,208 at 14.22
1.5%
2 Mar 2026
TANG KEVIN Director · indirect
Bought 2×
$2.84M 199,353 at 14.26
1.7%
27 Feb 2026
TANG KEVIN Director · indirect
Bought 3×
$7.23M 516,439 at 13.99
4.6%
5 Aug 2025
TANG KEVIN Director · indirect
Bought
$2.34M 200,000 at 11.68
1.8%
4 Aug 2025
TANG KEVIN Director · indirect
Bought
$1.13M 100,000 at 11.34
0.9%
1 Aug 2025
TANG KEVIN Director · indirect
Bought
$10.12M 1,000,000 at 10.12
10.0%
Largest buy in 3 yrs
1 Aug 2025
Keenan Greg Chief Medical Officer
Sold at will
$210.00K 20,000 at 10.50
13.0%
Not planned
7 Mar 2025
Keenan Greg Chief Medical Officer
Sold at will
$68.35K 8,305 at 8.23
5.1%
Not planned
4 Mar 2025
TANG KEVIN Director · indirect
Bought 3×
$5.95M 748,038 at 7.96
8.1%
Largest buy in 3 yrs
4 Mar 2025
Greenleaf Peter Chief Executive Officer
Sold at will
$1.31M 164,947 at 7.92
8.4%
Not planned
4 Mar 2025
Donley Matthew Maxwell Chief Operating Officer
Sold at will
$467.21K 58,991 at 7.92
8.0%
Not planned
4 Mar 2025
Robertson Stephen P. EVP, General Counsel
Sold at will
$456.25K 57,607 at 7.92
10.2%
Not planned
4 Mar 2025
Miller Joseph M Chief Financial Officer
Sold at will
$444.74K 56,154 at 7.92
8.9%
Not planned
3 Mar 2025
TANG KEVIN Director · indirect
Bought 2×
$3.63M 452,682 at 8.01
5.1%
3 Mar 2025
Greenleaf Peter Chief Executive Officer
Sold at will
$1.56M 195,593 at 8.00
9.1%
Not planned
3 Mar 2025
Donley Matthew Maxwell Chief Operating Officer
Sold at will
$527.22K 65,902 at 8.00
8.2%
Not planned
3 Mar 2025
Robertson Stephen P. EVP, General Counsel
Sold at will
$518.98K 64,872 at 8.00
10.3%
Not planned
3 Mar 2025
Miller Joseph M Chief Financial Officer
Sold at will
$494.87K 61,859 at 8.00
8.9%
Not planned
3 Mar 2025
Keenan Greg Chief Medical Officer
Sold at will
$97.91K 12,239 at 8.00
7.0%
Not planned
28 Feb 2025
TANG KEVIN Director · indirect
Bought
$3.13M 399,280 at 7.85
4.7%
9 Dec 2024
TANG KEVIN Director · indirect
Bought
$4.55M 500,000 at 9.09
6.3%
Largest buy in 3 yrs
6 Dec 2024
TANG KEVIN Director · indirect
Bought
$3.60M 400,000 at 9.01
5.3%
Largest buy in 3 yrs
5 Dec 2024
TANG KEVIN Director · indirect
Bought
$2.67M 300,000 at 8.91
4.1%
First buy on file
11 Nov 2024
Smith Karen L. Director
Sold at will
$44.18K 5,241 at 8.43
29.3%
Not planned
11 Nov 2024
Sold at will
$38.42K 4,557 at 8.43
25.4%
Not planned
6 Aug 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$96.90K 18,249 at 5.31
3.8%
Not planned
21 May 2024
Sold at will
$32.32K 5,630 at 5.74
23.2%
Not planned
21 May 2024
Leversage Jill Director
Sold at will
$32.20K 5,610 at 5.74
30.3%
Not planned
21 May 2024
Billen Daniel Director
Sold at will
$30.15K 5,252 at 5.74
15.7%
Not planned
21 May 2024
Jayne David R.W. Director
Sold at will
$28.39K 4,946 at 5.74
10.0%
Not planned
21 May 2024
Sold at will
$2.98K 520 at 5.74
2.9%
Not planned
6 Mar 2024
Greenleaf Peter Chief Executive Officer
Sold at will
$711.09K 126,981 at 5.60
7.7%
Not planned
6 Mar 2024
Robertson Stephen P. EVP, General Counsel
Sold at will
$323.37K 57,745 at 5.60
11.5%
Not planned
6 Mar 2024
Donley Matthew Maxwell EVP, Ops & Strategy
Sold at will
$224.06K 40,665 at 5.51
6.5%
Not planned
6 Mar 2024
Miller Joseph M Chief Financial Officer
Sold at will
$194.94K 34,811 at 5.60
6.6%
Not planned
6 Mar 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$99.55K 17,777 at 5.60
3.6%
Not planned
27 Feb 2024
Knappertz Volker EVP, Research and Development
Sold at will
$30.07K 4,930 at 6.10
1.5%
Not planned
20 Feb 2024
Knappertz Volker EVP, Research and Development
Sold at will
$137.80K 25,146 at 5.48
7.2%
Not planned
20 Feb 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$86.95K 15,867 at 5.48
3.1%
Not planned
23 May 2023
Jayne David R.W. Director
Sold at will
$98.33K 8,733 at 11.26
15.0%
Not planned
23 May 2023
Sold at will
$54.25K 4,818 at 11.26
16.6%
Not planned
23 May 2023
Leversage Jill Director
Sold at will
$54.22K 4,815 at 11.26
20.6%
Not planned
23 May 2023
Billen Daniel Director
Sold at will
$52.36K 4,650 at 11.26
12.2%
Not planned
19 May 2023
Hagan Joseph P Director
Sold at will
$2.88K 272 at 10.58
2.2%
Not planned
2 Mar 2023
Greenleaf Peter Chief Executive Officer
Sold, plan not stated
$292.79K 32,750 at 8.94
3.2%
Showing 1–50 of 103. Page 1 of 3 Older →